Global Pain Management Drugs Market Size, Share, Trends and Forecast 2022-2030

Market Analysis and Insights: Global Pain Management Drugs Market
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

The global Pain Management Drugs market size is projected to reach US$ 44550 million by 2028, from US$ 35360 million in 2021, at a CAGR of 3.3% during 2022-2028.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pain Management Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pain Management Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pain Management Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pain Management Drugs market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Pain Management Drugs market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Pain Management Drugs Breakdown Data by Type

Generic Opioids

Branded Opioids

NSAIDs

Others

Pain Management Drugs Breakdown Data by Application

Hospitals

Drugstores

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

GSK

Pfizer

Grunenthal

Sanofi

Bayer

AstraZeneca

Eli Lilly

Endo

Merck

Yunnan Baiyao

Teikoku Seiyaku

Teva

J&J

Assertio Therapeutics

Allergan

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pain Management Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Generic Opioids

1.2.3 Branded Opioids

1.2.4 NSAIDs

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pain Management Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Pain Management Drugs Market Perspective (2017-2028)

2.2 Pain Management Drugs Growth Trends by Region

2.2.1 Pain Management Drugs Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Pain Management Drugs Historic Market Size by Region (2017-2022)

2.2.3 Pain Management Drugs Forecasted Market Size by Region (2023-2028)

2.3 Pain Management Drugs Market Dynamics

2.3.1 Pain Management Drugs Industry Trends

2.3.2 Pain Management Drugs Market Drivers

2.3.3 Pain Management Drugs Market Challenges

2.3.4 Pain Management Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pain Management Drugs Players by Revenue

3.1.1 Global Top Pain Management Drugs Players by Revenue (2017-2022)

3.1.2 Global Pain Management Drugs Revenue Market Share by Players (2017-2022)

3.2 Global Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pain Management Drugs Revenue

3.4 Global Pain Management Drugs Market Concentration Ratio

3.4.1 Global Pain Management Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pain Management Drugs Revenue in 2021

3.5 Pain Management Drugs Key Players Head office and Area Served

3.6 Key Players Pain Management Drugs Product Solution and Service

3.7 Date of Enter into Pain Management Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pain Management Drugs Breakdown Data by Type

4.1 Global Pain Management Drugs Historic Market Size by Type (2017-2022)

4.2 Global Pain Management Drugs Forecasted Market Size by Type (2023-2028)

5 Pain Management Drugs Breakdown Data by Application

5.1 Global Pain Management Drugs Historic Market Size by Application (2017-2022)

5.2 Global Pain Management Drugs Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Pain Management Drugs Market Size (2017-2028)

6.2 North America Pain Management Drugs Market Size by Type

6.2.1 North America Pain Management Drugs Market Size by Type (2017-2022)

6.2.2 North America Pain Management Drugs Market Size by Type (2023-2028)

6.2.3 North America Pain Management Drugs Market Share by Type (2017-2028)

6.3 North America Pain Management Drugs Market Size by Application

6.3.1 North America Pain Management Drugs Market Size by Application (2017-2022)

6.3.2 North America Pain Management Drugs Market Size by Application (2023-2028)

6.3.3 North America Pain Management Drugs Market Share by Application (2017-2028)

6.4 North America Pain Management Drugs Market Size by Country

6.4.1 North America Pain Management Drugs Market Size by Country (2017-2022)

6.4.2 North America Pain Management Drugs Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Pain Management Drugs Market Size (2017-2028)

7.2 Europe Pain Management Drugs Market Size by Type

7.2.1 Europe Pain Management Drugs Market Size by Type (2017-2022)

7.2.2 Europe Pain Management Drugs Market Size by Type (2023-2028)

7.2.3 Europe Pain Management Drugs Market Share by Type (2017-2028)

7.3 Europe Pain Management Drugs Market Size by Application

7.3.1 Europe Pain Management Drugs Market Size by Application (2017-2022)

7.3.2 Europe Pain Management Drugs Market Size by Application (2023-2028)

7.3.3 Europe Pain Management Drugs Market Share by Application (2017-2028)

7.4 Europe Pain Management Drugs Market Size by Country

7.4.1 Europe Pain Management Drugs Market Size by Country (2017-2022)

7.4.2 Europe Pain Management Drugs Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pain Management Drugs Market Size (2017-2028)

8.2 Asia-Pacific Pain Management Drugs Market Size by Type

8.2.1 Asia-Pacific Pain Management Drugs Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Pain Management Drugs Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Pain Management Drugs Market Share by Type (2017-2028)

8.3 Asia-Pacific Pain Management Drugs Market Size by Application

8.3.1 Asia-Pacific Pain Management Drugs Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Pain Management Drugs Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Pain Management Drugs Market Share by Application (2017-2028)

8.4 Asia-Pacific Pain Management Drugs Market Size by Region

8.4.1 Asia-Pacific Pain Management Drugs Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Pain Management Drugs Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Pain Management Drugs Market Size (2017-2028)

9.2 Latin America Pain Management Drugs Market Size by Type

9.2.1 Latin America Pain Management Drugs Market Size by Type (2017-2022)

9.2.2 Latin America Pain Management Drugs Market Size by Type (2023-2028)

9.2.3 Latin America Pain Management Drugs Market Share by Type (2017-2028)

9.3 Latin America Pain Management Drugs Market Size by Application

9.3.1 Latin America Pain Management Drugs Market Size by Application (2017-2022)

9.3.2 Latin America Pain Management Drugs Market Size by Application (2023-2028)

9.3.3 Latin America Pain Management Drugs Market Share by Application (2017-2028)

9.4 Latin America Pain Management Drugs Market Size by Country

9.4.1 Latin America Pain Management Drugs Market Size by Country (2017-2022)

9.4.2 Latin America Pain Management Drugs Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pain Management Drugs Market Size (2017-2028)

10.2 Middle East & Africa Pain Management Drugs Market Size by Type

10.2.1 Middle East & Africa Pain Management Drugs Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Pain Management Drugs Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Pain Management Drugs Market Share by Type (2017-2028)

10.3 Middle East & Africa Pain Management Drugs Market Size by Application

10.3.1 Middle East & Africa Pain Management Drugs Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Pain Management Drugs Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Pain Management Drugs Market Share by Application (2017-2028)

10.4 Middle East & Africa Pain Management Drugs Market Size by Country

10.4.1 Middle East & Africa Pain Management Drugs Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Pain Management Drugs Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Pain Management Drugs Introduction

11.1.4 GSK Revenue in Pain Management Drugs Business (2017-2022)

11.1.5 GSK Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Pain Management Drugs Introduction

11.2.4 Pfizer Revenue in Pain Management Drugs Business (2017-2022)

11.2.5 Pfizer Recent Developments

11.3 Grunenthal

11.3.1 Grunenthal Company Details

11.3.2 Grunenthal Business Overview

11.3.3 Grunenthal Pain Management Drugs Introduction

11.3.4 Grunenthal Revenue in Pain Management Drugs Business (2017-2022)

11.3.5 Grunenthal Recent Developments

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Pain Management Drugs Introduction

11.4.4 Sanofi Revenue in Pain Management Drugs Business (2017-2022)

11.4.5 Sanofi Recent Developments

11.5 Bayer

11.5.1 Bayer Company Details

11.5.2 Bayer Business Overview

11.5.3 Bayer Pain Management Drugs Introduction

11.5.4 Bayer Revenue in Pain Management Drugs Business (2017-2022)

11.5.5 Bayer Recent Developments

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Pain Management Drugs Introduction

11.6.4 AstraZeneca Revenue in Pain Management Drugs Business (2017-2022)

11.6.5 AstraZeneca Recent Developments

11.7 Eli Lilly

11.7.1 Eli Lilly Company Details

11.7.2 Eli Lilly Business Overview

11.7.3 Eli Lilly Pain Management Drugs Introduction

11.7.4 Eli Lilly Revenue in Pain Management Drugs Business (2017-2022)

11.7.5 Eli Lilly Recent Developments

11.8 Endo

11.8.1 Endo Company Details

11.8.2 Endo Business Overview

11.8.3 Endo Pain Management Drugs Introduction

11.8.4 Endo Revenue in Pain Management Drugs Business (2017-2022)

11.8.5 Endo Recent Developments

11.9 Merck

11.9.1 Merck Company Details

11.9.2 Merck Business Overview

11.9.3 Merck Pain Management Drugs Introduction

11.9.4 Merck Revenue in Pain Management Drugs Business (2017-2022)

11.9.5 Merck Recent Developments

11.10 Yunnan Baiyao

11.10.1 Yunnan Baiyao Company Details

11.10.2 Yunnan Baiyao Business Overview

11.10.3 Yunnan Baiyao Pain Management Drugs Introduction

11.10.4 Yunnan Baiyao Revenue in Pain Management Drugs Business (2017-2022)

11.10.5 Yunnan Baiyao Recent Developments

11.11 Teikoku Seiyaku

11.11.1 Teikoku Seiyaku Company Details

11.11.2 Teikoku Seiyaku Business Overview

11.11.3 Teikoku Seiyaku Pain Management Drugs Introduction

11.11.4 Teikoku Seiyaku Revenue in Pain Management Drugs Business (2017-2022)

11.11.5 Teikoku Seiyaku Recent Developments

11.12 Teva

11.12.1 Teva Company Details

11.12.2 Teva Business Overview

11.12.3 Teva Pain Management Drugs Introduction

11.12.4 Teva Revenue in Pain Management Drugs Business (2017-2022)

11.12.5 Teva Recent Developments

11.13 J&J

11.13.1 J&J Company Details

11.13.2 J&J Business Overview

11.13.3 J&J Pain Management Drugs Introduction

11.13.4 J&J Revenue in Pain Management Drugs Business (2017-2022)

11.13.5 J&J Recent Developments

11.14 Assertio Therapeutics

11.14.1 Assertio Therapeutics Company Details

11.14.2 Assertio Therapeutics Business Overview

11.14.3 Assertio Therapeutics Pain Management Drugs Introduction

11.14.4 Assertio Therapeutics Revenue in Pain Management Drugs Business (2017-2022)

11.14.5 Assertio Therapeutics Recent Developments

11.15 Allergan

11.15.1 Allergan Company Details

11.15.2 Allergan Business Overview

11.15.3 Allergan Pain Management Drugs Introduction

11.15.4 Allergan Revenue in Pain Management Drugs Business (2017-2022)

11.15.5 Allergan Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer